MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Import this data to Google Sheets with:

=jivedata("MDGL","financials")

Full statements spill as a table. For one cell: =jivedata("MDGL","Revenue") or =jivedata("MDGL","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

MADRIGAL PHARMACEUTICALS, INC.

MDGL • CIK 0001157601

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	—	$180,133	$958,403	$1,427,940
Operating Income (Loss)	$-380,496	$-497,875	$-300,097	$-152,651
Investment Income, Interest	$19,578	$46,654	$37,364	$33,045
InterestExpenseNonoperating	—	$14,671	$22,309	$32,125
Gain (Loss) on Extinguishment of Debt	—	—	$-2,779	$0
Other Nonoperating Income (Expense)	—	—	$-463	$-3,732
Net Income (Loss) Attributable to Parent	$-373,630	$-465,892	$-288,284	$-155,463
Operating Costs and Expenses	—	—	$56,148	$129,117
Research and Development Expense (Excluding Acquired in Process Cost)	$272,350	$236,718	$388,525	$387,893
Selling, General and Administrative Expense	—	$435,057	$813,827	$1,063,581
Operating Expenses	$380,496	—	$1,258,500	$1,580,591
Weighted Average Number of Shares Outstanding, Basic	18,687,774	21,272,962	22,434,310	29,315,162

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$99,915	$100,019	$198,693	$514,642
Restricted Cash, Current	—	$5,000	$5,090	$805
Property, Plant and Equipment, Net	$1,553	$2,190	$1,499	$13,959
Debt Securities, Available-for-sale, Current	$534,216	$826,232	$784,866	$446,324
Finite-Lived Intangible Assets, Net	—	$4,729	$7,381	$7,091
Preferred Stock, Shares Outstanding	2,369,797	2,369,797	2,369,797	2,369,797
Accounts Receivable, after Allowance for Credit Loss, Current	—	$53,822	$134,476	$227,377
Operating Lease, Right-of-Use Asset	$1,713	$2,401	$4,939	$12,847
Inventory, Net	—	$34,068	$74,841	$122,589
Assets	$640,547	$1,042,247	$1,259,589	$1,434,389
Prepaid Expense and Other Assets, Current	$3,150	$13,786	$47,804	$75,372
Assets, Current	$637,281	$1,032,927	$1,245,770	$1,387,109
Liabilities	$235,214	$287,864	$656,900	$807,448
Accounts Payable, Current	$28,041	$43,599	$48,878	$61,367
Accrued Liabilities, Current	$89,980	$124,695	$260,392	$391,864
Operating Lease, Liability, Current	$527	$983	$1,018	$1,013
Liabilities, Current	$118,548	$169,277	$310,288	$454,244
Long-term Debt, Excluding Current Maturities	$115,480	$117,569	$339,881	$341,275
Operating Lease, Liability, Noncurrent	$1,186	$1,018	$6,731	$11,929
Liabilities, Noncurrent	$116,666	$118,587	$346,612	$353,204
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$2	$2	$2	$2
Additional Paid in Capital, Common Stock	$1,741,153	$2,556,095	$2,692,280	$2,816,022
Accumulated Other Comprehensive Income (Loss), Net of Tax	$468	$468	$873	$-1,729
Retained Earnings (Accumulated Deficit)	$-1,336,290	$-1,802,182	$-2,090,466	$-2,187,354
Stockholders' Equity Attributable to Parent	$405,333	$754,383	$602,689	$626,941
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Common Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	19,875,427	22,004,679	22,842,073	23,221,744

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	—	—	$13	$-357
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-231,634	$5,104	$98,764	$214,753
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$99,915	$105,019	$203,783	$247,325
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-373,630	$-465,892	$-288,284	$-288,284
Net Cash Provided by (Used in) Operating Activities	$-324,230	$-455,572	$-189,553	$-157,010
Payments to Acquire Debt Securities, Available-for-sale	$834,439	$1,131,207	$1,047,510	$654,531
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	$333,398	$863,283	$1,083,297	$1,013,929
Payments to Acquire Intangible Assets	—	$5,000	$3,000	$0
Payments to Acquire Property, Plant, and Equipment	$1,479	$1,462	$467	$11,640
Net Cash Provided by (Used in) Investing Activities	$-502,520	$-274,386	$32,320	$347,758
Proceeds from Issuance of Secured Debt	—	—	$350,000	$0
Payments of Debt Issuance Costs	$363	$0	$10,407	$983
Repayments of Secured Debt	—	—	$121,664	$0
Net Cash Provided by (Used in) Financing Activities	$595,116	$735,062	$255,984	$24,362
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$1,628	$1,330	$3,982	$8,566
Share-based Payment Arrangement, Noncash Expense	$49,735	$79,880	$98,130	$134,124
Depreciation, Depletion and Amortization	$527	$1,096	$1,506	$1,550
Amortization of Debt Issuance Costs and Discounts	$2,414	$2,089	$1,604	$1,861
Gain (Loss) on Extinguishment of Debt	—	—	$-2,779	$0
Increase (Decrease) in Accounts Receivable	—	$53,822	$80,654	$114,114
Increase (Decrease) in Inventories	—	$34,068	$36,978	$60,532
Increase (Decrease) in Prepaid Expense and Other Assets	$555	$10,636	$34,018	$40,363
Increase (Decrease) in Accounts Payable, Trade	$4,210	$15,558	$5,279	$16,810
Increase (Decrease) in Accrued Liabilities	$-1,481	$34,715	$131,902	$44,096

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("MDGL","financials")

Full statements spill as a table. For one cell: =jivedata("MDGL","Revenue") or =jivedata("MDGL","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.